Skip to main content
Year archive

AMPLIA THERAPEUTICS LIMITED — 2022 filings

All 55 regulatory filings released by AMPLIA THERAPEUTICS LIMITED (ATX) in 2022, sourced directly from the official regulator.

55 Filings
2022 Period
2022 filings (55)
Filing Released Lang
Letter to Shareholders End of Year Summary and 2023 Plans 11 pages 3.4MB
Investor Presentation
2022-12-19 English
Final Director's Interest Notice - Dr. John Lambert 3 pages 311.1KB
Director's Dealing
2022-11-30 English
ACCENT Trial Recruitment Progress 1 page 107.7KB
Regulatory Filings
2022-11-28 English
Appendix 4D and Financial Report Half Year ended 30 Sep 22 25 pages 2.3MB
Interim / Quarterly Report
2022-11-17 English
Amplia Appoints Dr Christopher Burns CEO & Managing Director 2 pages 139.0KB
Board/Management Information
2022-11-06 English
Quarterly Activities and Cashflow Reports - Sep 2022 Qtr 8 pages 406.3KB
Interim / Quarterly Report
2022-10-27 English
Notification regarding unquoted securities - ATX 7 pages 30.2KB
Share Issue/Capital Change
2022-10-09 English
AMP886 Activity in Acute Myeloid Leukemia 3 pages 246.2KB
Regulatory Filings
2022-10-02 English
AACR Conference Presentation 2 pages 870.8KB
Investor Presentation
2022-09-13 English
CEO Resignation 1 page 107.8KB
Board/Management Information
2022-09-11 English
Change of Director's Interest Notice - Mrs. Jane Bell 4 pages 287.0KB
Director's Dealing
2022-09-06 English
Change of Director's Interest Notice - Dr. Christopher Burns 3 pages 287.6KB
Director's Dealing
2022-09-06 English
Change of Director's Interest Notice - Dr. Robert Peach 4 pages 291.4KB
Director's Dealing
2022-09-06 English
Change of Director's Interest Notice - Dr. Warwick Tong 3 pages 287.9KB
Director's Dealing
2022-09-06 English
Notification regarding unquoted securities - ATX 7 pages 31.3KB
Share Issue/Capital Change
2022-09-06 English
Change of Director's Interest Notice - Dr. John Lambert 4 pages 304.0KB
Director's Dealing
2022-09-05 English
Notification of cessation of securities - ATX 4 pages 24.3KB
Regulatory Filings
2022-09-01 English
Amplia Receives $1.8m R&D Tax Incentive 1 page 108.
Capital/Financing Update
2022-08-30 English
CEO & Managing Director Presentation to AGM 30 pages 6.2MB
AGM Information
2022-08-24 English
Results of Annual General Meeting 2 pages 350.8KB
Declaration of Voting Results & Voting Rights Announcements
2022-08-24 English
Employee Security Ownership Plan 9 pages 271.5KB
Governance Information
2022-08-16 English
Annual General Meeting - ESOP and New Constitution 3 pages 170.9KB
AGM Information
2022-08-16 English
Change of Director's Interest Notice - Dr. Warwick Tong 3 pages 286.6KB
Director's Dealing
2022-08-03 English
First Patient Recruited to ACCENT Trial in Pancreatic Cancer 2 pages 138.2KB
Regulatory Filings
2022-08-01 English
Quarterly Activities and Cashflow Reports - June 2022 Qtr 8 pages 311.0KB
Interim / Quarterly Report
2022-07-27 English
Presentation at Major Pancreatic Cancer Conference 1
Investor Presentation
2022-07-24 English
Notice of Annual General Meeting/Proxy - YE 31 March 2022 28 pages 609.4KB
AGM Information
2022-07-21 English
Change of Director's Interest Notice - Dr. Warwick Tong 4 pages 282.1KB
Director's Dealing
2022-07-06 English
Change of Director's Interest Notice - Dr. John Lambert 4 pages 297.4KB
Director's Dealing
2022-07-06 English
Change of Director's Interest Notice - Dr. Robert Peach 4 pages 288.6KB
Director's Dealing
2022-07-06 English
Change of Director's Interest Notice - Dr. Chistopher Burns 3 pages 284.6KB
Director's Dealing
2022-07-06 English
Notification of cessation of securities - ATX 4 pages 24.4KB
Transaction in Own Shares
2022-07-04 English
Application for quotation of securities - ATX 6 pages 27.8KB
Share Issue/Capital Change
2022-06-29 English
Annual General Meeting to be held Thursday 25 August 2022 1
AGM Information
2022-06-28 English
Registered Office and Principal Place of Business 1
Regulatory Filings
2022-06-23 English
Application for quotation of securities - ATX 6 pages 27.8KB
Share Issue/Capital Change
2022-06-08 English
Notification of Expiry of Unlisted Options 2 pages 216.9KB
Capital/Financing Update
2022-06-08 English
AMP945 Shows Efficacy in Model of Lung Fibrosis 2 pages 190.0KB
Regulatory Filings
2022-06-01 English
Preliminary Final Report and Annual Report YE 31 March 2022 63 pages 2.7MB
Annual Report
2022-05-29 English
2022 Corporate Governance Statement 16 pages 361.1KB
Governance Information
2022-05-29 English
App 4G - Key to Corporate Governance Disclosures 12 pages 369.6KB
Regulatory Filings
2022-05-29 English
Amplia Receives Second Ethics Clearance for Phase 2 Trial 1
Regulatory Filings
2022-05-12 English
Amplia Presentation to 16th Bioshares Biotech Summit 23 pages 10.9MB
Investor Presentation
2022-05-11 English
AMP945 Pre-IND Meeting Outcome 2 pages 139.3KB
Regulatory Filings
2022-05-08 English
Quarterly Activities and Cashflow Reports - March 2022 Qtr 8 pages 320.2KB
Interim / Quarterly Report
2022-04-18 English
Ethics Clearance Phase 2 Trial - Pancreatic Cancer Patients 2 pages 194.1KB
Regulatory Filings
2022-04-05 English
Notification of cessation of securities - ATX 4 pages 24.3KB
Share Issue/Capital Change
2022-04-04 English
AMP945 Improves Survival in Human Pancreatic Cancer Model 2 pages 241.1KB
Capital/Financing Update
2022-02-16 English
ATX Abstract accepted for presentation at Cancer Conference 1
Regulatory Filings
2022-02-14 English
Sale of Unmarketable Parcels of Shares 10 pages 679.8KB
Share Issue/Capital Change
2022-02-13 English
Change of Director's Interest Notice - Jane Bell 4 pages 250.2KB
Director's Dealing
2022-02-09 English
Amplia Investor Presentation - February 2022 30 pages 11.5MB
Investor Presentation
2022-01-31 English
Quarterly Activities and Cashflow Reports - Dec 2021 Qtr 8 pages 319.3KB
Interim / Quarterly Report
2022-01-23 English
Notification regarding unquoted securities - ATX 7 pages 30.1KB
Share Issue/Capital Change
2022-01-18 English
Amplia Completes Manufacture of AMP945 for Planned Trials 2 pages 139.3KB
Regulatory Filings
2022-01-12 English